| Drug Name: | Olopatadine (113806-05-6) |
|---|---|
| PubChem ID: | 5281071 |
| SMILES: | CN(C)CC/C=C1/C2=CC=CC=C2COC3=C1C=C(C=C3)CC(=O)O |
| InchiKey: | JBIMVDZLSHOPLA-LSCVHKIXSA-N |
| Therapeutic Category: | Analgesics, Anti-Allergic Agents, Anti-Inflammatory Agents, Antirheumatic Agents, Histamine Agents, Histamine Antagonists, Histamine H1 Antagonists, Neurotransmitter Agents, Peripheral Nervous System Agents, Sensory System Agents |
| Molecular Weight (dalton) | : | 337.419 |
| LogP | : | 3.5895 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 49.77 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category